Comparison of the Effect of Tranexamic Acid and Misoprostol on Blood Loss During and After Cesarean Section: A Randomized Clinical Trial

Document Type : Original Article

Authors

1 Research Assistant, ENT-HNS Research Center,Hazrat-e- Rasool Hospital,Iran University of Medical Sciences, Tehran, Iran

2 Assistant professor of obstructs and gynecology, Bandar abas Medical University of Medical Science, Hormozgan, Iran

3 Resident of gynecology and obstetrics, Bandar abas Medical University of Medical Science, Hormozgan, Iran

Abstract

Background: One of the methods proposed for the reduction of blood loss during and after cesarean section is the use of such drugs as Tranexamic acid and Misoprostol. Therefore, the present study aimed to compare the effect of Tranexamic acid and Misoprostol on blood loss during and after cesarean section.

Methods: This randomized clinical trial was performed in Dr. Ali Shariati and Persian Gulf Hospitals of Bandar Abbas,
Iran, between 2015 and 2016. The study population included all candidates for the cesarean section. A total of 300 pregnant women aged 18-40 years with a gestational age of 37-42 weeks were included and assigned to three groups (n=100 in each group): Group A received tranexamic acid, group B received misoprostol, and group C received 200 cc normal saline. During cesarean section, all patients received 20 and 30 units of oxytocin, respectively. The level of blood loss during the operation was determined after measuring the whole blood volume suctioned after the removal of the placenta, as well as differences in the weight of bloody sterile pads and surgical sheets before and after the operation.

Results: Based on the results, the mean scores of hemoglobin before the operation were obtained at 11.96±1, 11.62±1.21, and 12.28±1.26mg/dl in the Tranexamic acid group, the Misoprostol group, and the placebo group, respectively, demonstrating a statistically significant difference (P=0.001). Postoperative hemoglobin level was reduced about 1.02±0.35 (10.9±0.99 mg/dl) in the Tranexamic acid group, 1.19±0.52 (10.46±1.04 mg/dl) in the Misoprostol group, and 1.36±0.50 (10.93±1.34 mg/dl) in the placebo group. There was a significant difference among the three groups in the amount of blood loss during and the first two hours after the operation (P<0.001). According to the post-hoc test analysis, there were significant differences between the two groups (P<0.001).

Conclusion: As evidenced by the obtained results, both medicines are effective in reducing the amount of blood loss
during and after cesarean section; nonetheless, Misoprostol is more effective than Tranexamic acid.

Keywords

Open Access Policy: This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/

References

1. Palley M. The Politics of Women's Health Care in the United States. Springer; 2014 Feb 24.
https://doi.org/10.1057/9781137008633
PMid:25279788 PMCid:PMC4184794
 
2. AbouZahr C. Global burden of maternal death and disability. British medical bulletin. 2003 Dec 1;67(1):1-1.
https://doi.org/10.1093/bmb/ldg015
PMid:14711750
 
3. Movafegh A, Eslamian L, Dorabadi A. Effect of intravenous tranexamic acid administration on blood loss during and after cesarean delivery. International Journal of Gynecology & Obstetrics. 2011 Dec 31;115(3):224-6.
https://doi.org/10.1016/j.ijgo.2011.07.015
PMid:21872857
 
4. Villar J, Valladares E, Wojdyla D, Zavaleta N, Carroli G, Velazco A, Shah A, Campodónico L, Bataglia V, Faundes A, Langer A. Caesarean delivery rates and pregnancy outcomes: the 2005 WHO global survey on maternal and perinatal health in Latin America. The Lancet. 2006 Jun 9;367(9525):1819-29.
https://doi.org/10.1016/S0140-6736(06)68704-7
PMid:16753484
 
5. Lapaire O, Schneider MC, Stotz M, Surbek DV, Holzgreve W, Hoesli IM. Oral misoprostol vs. intravenous oxytocin in reducing blood loss after emergency cesarean delivery. International Journal of Gynecology & Obstetrics. 2006 Oct 1;95(1):2-7.
https://doi.org/10.1016/j.ijgo.2006.05.031
PMid:16934269
 
6. Sood AK, Singh S. Sublingual misoprostol to reduce blood loss at cesarean delivery. The Journal of Obstetrics and Gynecology of India. 2012 Apr 1;62(2):162-7.
https://doi.org/10.1007/s13224-012-0168-2
PMid:23543254 PMCid:PMC3425684
 
7. Brown RS, Thwaites BK, Mongan PD. Tranexamic acid is effective in decreasing postoperative bleeding and transfusions in primary coronary artery bypass operations: a double-blind, randomized, placebo-controlled trial. Anesthesia & Analgesia. 1997 Nov 1;85(5):963-70.
https://doi.org/10.1097/00000539-199711000-00003
PMid:9356085
 
8. Ido K, Neo M, Asada Y, Kondo K, Morita T, Sakamoto T, Hayashi R, Kuriyama S. Reduction of blood loss using tranexamic acid in total knee and hip arthroplasties. Archives of orthopaedic and trauma surgery. 2000 Aug 8;120(9):518-20.
https://doi.org/10.1007/s004029900132
PMid:11011672
 
9. Dunn CJ, Goa KL. Tranexamic acid. Drugs. 1999 Jun 1;57(6):1005-32.
https://doi.org/10.2165/00003495-199957060-00017
PMid:10400410
 
10. Waterstone M, Murphy JD, Bewley S, Wolfe C. Incidence and predictors of severe obstetric morbidity: case-control studyCommentary: Obstetric morbidity data and the need to evaluate thromboembolic disease. Bmj. 2001 May 5;322(7294):1089-94.
https://doi.org/10.1136/bmj.322.7294.1089
PMid:11337436 PMCid:PMC31259
 
11. Hogan MC, Foreman KJ, Naghavi M, Ahn SY, Wang M, Makela SM, Lopez AD, Lozano R, Murray CJ. Maternal mortality for 181 countries, 1980-2008: a systematic analysis of progress towards Millennium Development Goal 5. The lancet. 2010 May 14;375(9726):1609-23.
https://doi.org/10.1016/S0140-6736(10)60518-1
PMid:20382417
 
12. Mousa HA, Alfirevic Z. Treatment for primary postpartum haemorrhage. Cochrane Database Syst Rev. 2003;1.
https://doi.org/10.1002/14651858.CD003249
 
13. Derman RJ, Kodkany BS, Goudar SS, Geller SE, Naik VA, Bellad MB, Patted SS, Patel A, Edlavitch SA, Hartwell T, Chakraborty H. Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: a randomised controlled trial. The Lancet. 2006 Oct 13;368(9543):1248-53.
https://doi.org/10.1016/S0140-6736(06)69522-6
PMid:17027730
 
14. Gungorduk K, Yıldırım G, Asıcıoğlu O, Gungorduk OC, Sudolmus S, Ark C. Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study. American journal of perinatology. 2011 Mar;28(03):233-40.
https://doi.org/10.1055/s-0030-1268238
PMid:20979013
 
15. Williams-Johnson JA, McDonald AH, Strachan GG, Williams EW. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. West Indian Medical Journal. 2010 Dec;59(6):612-24.
 
16. Butwick AJ, Walsh EM, Kuzniewicz M, Li SX, Escobar GJ. Patterns and predictors of severe postpartum anemia after Cesarean section. Transfusion. 2017 Jan 1;57(1):36-44.
https://doi.org/10.1111/trf.13815
PMid:27618767 PMCid:PMC5243180
 
17. Saghaei M. Random allocation software for parallel group randomized trials. BMC medical research methodology. 2004 Nov 9;4(1):26.
https://doi.org/10.1186/1471-2288-4-26
PMid:15535880 PMCid:PMC533876
 
18. Robinson N, Kapungu C, Carnahan L, Geller S. Recommendations for scale‐up of community‐based misoprostol distribution programs. International Journal of Gynecology & Obstetrics. 2014 Jun 1;125(3):285-8.
https://doi.org/10.1016/j.ijgo.2013.12.005
PMid:24680582
 
19. Vallera C, Choi LO, Cha CM, Hong RW. Uterotonic Medications: Oxytocin, Methylergonovine, Carboprost, Misoprostol. Anesthesiology Clinics. 2017 Mar 30.
https://doi.org/10.1016/j.anclin.2017.01.007
PMid:28526143
 
20. Zavoshti FR, Andrews FM. Therapeutics for Equine Gastric Ulcer Syndrome. Veterinary Clinics of North America: Equine Practice. 2017 Apr 30;33(1):141-62.
https://doi.org/10.1016/j.cveq.2016.11.004
PMid:28325176
 
21. Lanas A, Chan FK. Peptic ulcer disease. The Lancet. 2017 Feb 25.
https://doi.org/10.1016/S0140-6736(16)32404-7
PMid:28242110
 
22. Aung HH, Soe A, Aye NN. Effect of misoprostol on the pharmacokinetics of sustained release diclofenac in Myanmar healthy male volunteers. Siriraj Medical Journal. 2017 Mar 24;69(2):75-9.
 
23. Acharya G, Al‐Sammarai MT, Patel N, Al‐Habib A, Kiserud T. A randomized, controlled trial comparing effect of oral misoprostol and intravenous syntocinon on intra‐operative blood loss during cesarean section. Acta obstetricia et gynecologica Scandinavica. 2001 Mar 1;80(3):245-50.
https://doi.org/10.1034/j.1600-0412.2001.080003245.x
PMid:11207490
 
24. Gai MY, Wu LF, Su QF, Tatsumoto K. Clinical observation of blood loss reduced by tranexamic acid during and after caesarian section: a multi-center, randomized trial. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2004 Feb 10;112(2):154-7.
https://doi.org/10.1016/S0301-2115(03)00287-2
PMid:14746950
 
25. Clark SL, Belfort MA, Dildy GA, Herbst MA, Meyers JA, Hankins GD. Maternal death in the 21st century: causes, prevention, and relationship to cesarean delivery. American journal of obstetrics and gynecology. 2008 Jul 31;199(1):36-e1.
https://doi.org/10.1016/j.ajog.2008.03.007
PMid:18455140
Razavi International Journal of Medicine
Volume 9, Issue 1
January 2021
Pages 7-13

Files

Share

How to cite

Statistics